Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BHMT | Q93088 | 11/20 | 0.63 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.63 |
| ▸ | NOS2 | P35228 | 2/20 | 0.58 |
| ▸ | NOS3 | P29474 | 1/20 | 0.58 |
| ▸ | NOS1 | P29475 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethionine SCHEMBL8967 | 1.00 | BHMT (0.63) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL8966 | 1.00 | BHMT (0.63) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL11571773 | 0.98 | BHMT (0.61) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL28999714 | 0.98 | BHMT (0.61) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL31567824 | 0.98 | BHMT (0.61) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL3348592 | 0.98 | BHMT (0.61) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL11572299 | 0.98 | BHMT (0.61) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL28989455 | 0.98 | BHMT (0.61) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL31087565 | 0.96 | BHMT (0.59) | BHMTBHMT2NOS2NOS3NOS1 | |
| Ethionine SCHEMBL29926199 | 0.96 | BHMT (0.59) | BHMTBHMT2NOS2NOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11274126-B2 | pH-sensitive cyclic peptides | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2022-03-15 | — | — | US | claimed |
| CN-105264064-B | O-phosphoserine export proteins and methods of producing O-phosphoserine using the same | CJ第一制糖株式会社 | 2020-08-18 | — | — | CN | claimed |
| US-20190119322-A1 | PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-04-25 | — | — | US | claimed |
| WO-2017189860-A1 | PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-11-02 | — | — | WO | claimed |
| US-9718921-B2 | Amphiphilic derivatives of thioether containing block copolypeptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-08-01 | — | — | US | claimed |
| US-20160002405-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | NATIONAL SCIENCE FOUNDATION | 2016-01-07 | — | — | US | claimed |
| EP-2961758-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | The Regents of The University of California (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150057433-A1 | PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-02-26 | — | — | US | claimed |
| WO-2014134203-A9 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-23 | — | — | WO | claimed |
| WO-2014134203-A1 | AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-04 | — | — | WO | claimed |
| US-20030162732-A1 | Combination of aminosugars and cysteine or cysteine derivatives | ASTION DEVELOPMENT A/S (DK) | 2003-08-28 | — | — | US | claimed |
| US-20030158118-A1 | Combination of cimetidine and cysteine derivatives for treating cancer | WEIDNER MORTEN SLOTH (DK) | 2003-08-21 | — | — | US | claimed |
| WO-2003045359-A2 | COMBINATION OF CIMETIDINE AND CYSTEINE DERIVATIVES FOR TREATING CANCER | ASTION ONCOLOGY APS (DK) | 2003-06-05 | — | — | WO | claimed |
| WO-2003002125-A2 | COMBINATION OF AMINOSUGARS AND CYSTEINE OR CYSTEINE DERIVATIVES | ASTION A/S (DK) | 2003-01-09 | — | — | WO | claimed |
| US-20260078141-A1 | 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-19 | — | — | US | disclosed |
| US-12558448-B2 | Immobilized pH indicator for biological indicator growth indication | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| US-12540162-B2 | Preparation of functional homocysteine residues in polypeptides and peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-03 | — | — | US | disclosed |
| WO-2003045359-A2 | COMBINATION OF CIMETIDINE AND CYSTEINE DERIVATIVES FOR TREATING CANCER | ASTION ONCOLOGY APS (DK) | 2003-06-05 | — | — | WO | disclosed |
| WO-2003002125-A2 | COMBINATION OF AMINOSUGARS AND CYSTEINE OR CYSTEINE DERIVATIVES | ASTION A/S (DK) | 2003-01-09 | — | — | WO | disclosed |
| US-4350627-A | Biologically active peptides | FARMITALIA CARLO ERBA S.P.A. (IT) | 1982-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162732-A1 | Combination of aminosugars and cysteine or cysteine derivatives | CBS, CTH, AADAT | BHMT 83/4885BHMT2 14/4885NOS2 570/4885 |
| US-11274126-B2 | pH-sensitive cyclic peptides | VIP, PHLPP1, PHLPP2 | BHMT 3952/4885BHMT2 3892/4885NOS2 2794/4885 |
| US-12558448-B2 | Immobilized pH indicator for biological indicator growth indication | ALPG, GUSB, HAO2 | BHMT 1156/4885BHMT2 3421/4885NOS2 823/4885 |
| US-20030158118-A1 | Combination of cimetidine and cysteine derivatives for treating cancer | MGMT, CMA1, CYSLTR2 | BHMT 204/4885BHMT2 60/4885NOS2 508/4885 |
| US-20190119322-A1 | PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES | BHMT2, BHMT, PTMS | BHMT 2/4885BHMT2 1/4885NOS2 477/4885 |
| US-12540162-B2 | Preparation of functional homocysteine residues in polypeptides and peptides | PTMS, AHCY, BHMT2 | BHMT 9/4885BHMT2 3/4885NOS2 630/4885 |
| US-20150057433-A1 | PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS | PTMS, TMT1A, PTMA | BHMT 123/4885BHMT2 61/4885NOS2 2246/4885 |
| US-20260078141-A1 | 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS | ALPG, UNG, UGDH | BHMT 2505/4885BHMT2 3822/4885NOS2 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.